அறிவியல் மற்றும் தொழில்நுட்பம் இல் தி மக்கள் குடியரசு ஆஃப் சீனா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவியல் மற்றும் தொழில்நுட்பம் இல் தி மக்கள் குடியரசு ஆஃப் சீனா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவியல் மற்றும் தொழில்நுட்பம் இல் தி மக்கள் குடியரசு ஆஃப் சீனா Today - Breaking & Trending Today

Aarti Drugs' unit gets approval under pharma PLI scheme


Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30. ....

Adhish Patil , Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Chief Financial Officer , Pharma Intermediates , Capital Market , Pharmaceutical Industry In China , Pharmaceuticals Policy , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Chemical Substance , Physical Sciences , Natural Sciences , Companies Based In , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் ,

Pharma stocks rally after cabinet approves PLI scheme


Shares of eight pharmaceutical companies rose by 0.5% to 3.4% after the cabinet approved Production Linked Incentive (PLI) scheme for pharmaceuticals segment.Hikal (up 3.46%), Neuland Laboratories (up 3.08%), IPCA Laboratories (up 2.85%), Alkem Laboratories (up 1.43%), Torrent Pharmaceutical (up 1.09%), Biocon (up 0.6%), Cadila Healthcare (up 0.58%) and Aurobindo Pharma (up 0.52%) were top gainers in pharmaceutical space.
The Union Cabinet on Wednesday approved Production Linked Incentive (PLI) scheme for pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.
The scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The scheme is also expected to bring in investment of Rs 15,000 crore in the pharmaceutical sector. ....

Aurobindo Pharma , Union Cabinet On , Production Linked Incentive , Neuland Laboratories , Alkem Laboratories , Torrent Pharmaceutical , Cadila Healthcare , Union Cabinet , Financial Year , Diagnostic Devices , Capital Market , Health Sciences , Health Care , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Pharmaceutical Industry , Pharmaceutical Space , அரவிந்தோ பார்மா , தொழிற்சங்கம் மந்திரி சபை ஆன் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , அல்கெம் ஆய்வகங்கள் , நீரோடை மருந்து , காடிலா சுகாதாரம் , தொழிற்சங்கம் மந்திரி சபை ,

Welcure Drugs & Pharmaceuticals reports standalone nil net profit/loss in the December 2020 quarter


Reported sales nilWelcure Drugs & Pharmaceuticals reported no net profit/loss in the quarter ended December 2020 as against net loss of Rs 0.01 crore during the previous quarter ended December 2019. There were no Sales reported in the quarter ended December 2020 and during the previous quarter ended December 2019.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news ....

Welcure Drugs Pharmaceuticals , Welcure Drugs , Capital Market , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Gss Infotech , Welcure Drugs Amp Pharmaceuticals , வரவேற்பு மருந்துகள் மருந்துகள் , வரவேற்பு மருந்துகள் , மூலதனம் சந்தை , மருந்துகள் பாலிஸீ , மருந்து தொழில் இல் சீனா , மருந்தகம் இல் சீனா , அறிவியல் மற்றும் தொழில்நுட்பம் இல் தி மக்கள் குடியரசு ஆஃப் சீனா , க்ஸ்ஸ் இன்ஃபோடெக் , வரவேற்பு மருந்துகள் ஆம்ப் மருந்துகள் ,